| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 12,833 | 9,949 | 9,487 | | Cost of Revenue | 10,456 | 8,556 | 7,535 | | | Gross Profit | 2,377 | 1,394 | 1,952 | | | Operating Expenses | | Research Development | 4,831 | 3,441 | 2,372 | | Selling General and Administrative | 10,226 | 8,178 | 5,184 | | Non Recurring | 42 | 660 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (12,722) | (10,885) | (5,603) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,334 | 1,551 | 26,236 | | Earnings Before Interest And Taxes | (7,388) | (9,333) | 20,633 | | Interest Expense | 16 | 9 | 1 | | Income Before Tax | (7,404) | (9,343) | 20,632 | | Income Tax Expense | 21 |
-
| 520 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,425) | (9,343) | 20,112 | | | Non-recurring Events | | Discontinued Operations | (800) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,225) | (9,343) | 20,112 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,225) | ($9,343) | $20,112 |
|
0.60% Nasdaq 
Income Statement
